+987.9%
MRNA vs VNQ
+14.0%
+973.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VNQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.2% | +9.9% | +7.5% |
| 7D | +20.6% | +6.8% | +13.8% | +8.2% |
| 30D | +27.1% | +10.0% | +17.2% | +6.6% |
| 3M | +353.4% | 0.0% | +353.4% | +358.9% |
| 6M | +446.3% | +4.5% | +441.8% | +422.7% |
| YTD | +776.2% | +13.9% | +762.2% | +597.6% |
| 1Y | +987.9% | +14.1% | +973.9% | +764.8% |
| All | +987.9% | +14.0% | +973.9% | +764.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VNQ.
Daily Out/Under-Performance
Portfolio return minus VNQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VNQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VNQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling